Regenera Pharma's Corporate Minority - II Round

Regenera Pharma raised a round of funding on January 02, 2018. Investors include aMoon Partners.

Regenera Pharma is developing a drug for the treatment of degenerative nerve diseases. Its first product is designed to treat a rare disease called nonarteritic anterior ischemic optic neuropathy (NAI…

Articles about Regenera Pharma's Corporate Minority - II Round: